Prelude Capital Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-12,229
| Closed | -$112K | – | 1346 |
|
|
2025
Q2 | $112K | Sell |
12,229
-3,138
| -20% | -$23.1K | 0.01% | 898 |
|
|
2025
Q1 | $122K | Sell |
15,367
-16,833
| -52% | -$123K | 0.01% | 1020 |
|
|
2024
Q4 | $175K | Buy |
32,200
+6,000
| +23% | +$36.7K | 0.01% | 1022 |
|
|
2024
Q3 | $189K | Buy |
26,200
+6,567
| +33% | +$60.1K | 0.01% | 1077 |
|
|
2024
Q2 | $213K | Buy |
19,633
+1,440
| +8% | +$18.5K | 0.01% | 973 |
|
|
2024
Q1 | $341K | Sell |
18,193
-3,786
| -17% | -$87.3K | 0.02% | 836 |
|
|
2023
Q4 | $476K | Buy |
21,979
+3,937
| +22% | +$78K | 0.03% | 545 |
|
|
2023
Q3 | $371K | Buy |
18,042
+9,025
| +100% | +$261K | 0.02% | 577 |
|
|
2023
Q2 | $424K | Sell |
9,017
-4,983
| -36% | -$248K | 0.03% | 530 |
|
|
2023
Q1 | $587K | Buy |
14,000
+1,978
| +16% | +$85K | 0.04% | 410 |
|
|
2022
Q4 | $459K | Sell |
12,022
-13,084
| -52% | -$500K | 0.02% | 602 |
|
|
2022
Q3 | $983K | Buy |
25,106
+133
| +0.5% | +$5.14K | 0.04% | 436 |
|
|
2022
Q2 | $807K | Buy |
24,973
+14,976
| +150% | +$502K | 0.02% | 606 |
|
|
2022
Q1 | $331K | Buy |
+9,997
| New | +$376K | 0.01% | 1038 |
|
|
2021
Q3 | – | Sell |
-4,812
| Closed | -$273K | – | 1992 |
|
|
2021
Q2 | $273K | Buy |
+4,812
| New | +$340K | 0.01% | 1241 |
|
|
2021
Q1 | – | Sell |
-7,574
| Closed | -$655K | – | 1780 |
|
|
2020
Q4 | $655K | Buy |
7,574
+1,866
| +33% | +$138K | 0.02% | 621 |
|
|
2020
Q3 | $349K | Sell |
5,708
-2,794
| -33% | -$142K | 0.02% | 515 |
|
|
2020
Q2 | $354K | Buy |
+8,502
| New | +$309K | 0.02% | 574 |
|
|
2020
Q1 | – | Sell |
-8,381
| Closed | -$605K | – | 1953 |
|
|
2019
Q4 | $605K | Buy |
8,381
+2,870
| +52% | +$353K | 0.02% | 515 |
|
|
2019
Q3 | $773K | Buy |
5,511
+2,519
| +84% | +$421K | 0.03% | 408 |
|
|
2019
Q2 | $548K | Buy |
+2,992
| New | +$511K | 0.03% | 479 |
|
|
2018
Q4 | – | Sell |
-1,818
| Closed | -$257K | – | 2116 |
|
|
2018
Q3 | $257K | Sell |
1,818
-1,231
| -40% | -$190K | 0.01% | 713 |
|
|
2018
Q2 | $477K | Sell |
3,049
-2
| -0.1% | -$314 | 0.03% | 550 |
|
|
2018
Q1 | $491K | Sell |
3,051
-769
| -20% | -$131K | 0.04% | 443 |
|
|
2017
Q4 | $629K | Sell |
3,820
-60
| -2% | -$5.82K | 0.05% | 360 |
|
|
2017
Q3 | $242K | Sell |
3,880
-1,180
| -23% | -$92.7K | 0.02% | 580 |
|
|
2017
Q2 | $403K | Hold |
5,060
| – | – | 0.04% | 376 |
|
|
2017
Q1 | $360K | Buy |
5,060
+159
| +3% | +$9.31K | 0.03% | 381 |
|
|
2016
Q4 | $250K | Buy |
+4,901
| New | +$231K | 0.03% | 493 |
|
Other funds holding SAGE
IA
HNB